HI

Harry IV Hall

Mr Hall has more than 28 years of experience in the global medical device industry and has held diverse general management roles including product development, global strategic marketing, commercial operations, and sales leadership. Prior to joining Next Science, I.V. was a member of the Global Leadership Team and R&D Leadership Team for DePuy Synthes, a subsidiary of Johnson & Johnson (NYSE: JNJ), and completed the launch of the first surgical robot developed by JNJ / DePuy Synthes. I.V. joined DePuy Synthes in 1997 where he held senior roles including: Global Vice President - MedTech R&D and Worldwide President - Trauma, Extremities, Craniomaxillofacial & Animal Health. As Worldwide President of Trauma, Extremities, Craniomaxillofacial and Animal Health, I.V. was responsible for a global portfolio and execution strategy for a US$3.2bn platform including upstream marketing and commercial planning in the Global Orthopaedic Unit of DePuy Synthes. In addition to managing over 1,100 staff across sales, marketing and R&D, I.V. created and sustained personal relationships with well over one hundred key opinion leaders worldwide.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
14/07/251,130,262N/A3,361,855N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
14/07/25
Exercise
465,131$0.140$65,118Conversion of securities
14/07/25
Issued
465,131$0.140$65,118Conversion of securities
16/09/24
Issued
1,814,394$0.248$450,000Issue of securities
16/09/24
Issued
3,361,855$0.134$450,000Issue of options
26/07/24
Exercise
465,131$0.275$127,911Conversion of securities